Core Viewpoint - The announcement highlights that a significant shareholder of Berry Genomics, Gao Yang, is subject to judicial enforcement regarding the forced liquidation of a portion of his shares due to a breach of contract with Guoxin Securities [1][2]. Group 1: Shareholder and Legal Actions - Gao Yang, the controlling shareholder of Berry Genomics, holds 31,988,723 shares, accounting for 9.05% of the total share capital [1]. - The Chengdu Financial Court has ordered the forced liquidation of 3,535,214 shares held by Gao Yang due to a breach of a stock pledge repurchase agreement with Guoxin Securities [1][2]. - The enforcement action is based on a legally effective arbitration ruling from the Shenzhen International Arbitration Court [1]. Group 2: Financial Performance - Berry Genomics reported net profits attributable to shareholders of -117 million yuan in 2021, -249 million yuan in 2022, -427 million yuan in 2023, and -192 million yuan in 2024 [3]. - The company's operating revenue for 2024 is 1,078 million yuan, a decrease of 6.36% from 2023, which had revenue of 1,151 million yuan [4]. - The net profit attributable to shareholders for 2024 improved by 54.96% compared to 2023, indicating a reduction in losses [4].

Group 1 - The core point of the announcement is that Hubei Hongtai Group has applied for an extension of the stock repurchase transaction for its pledged shares in Hubei Energy Group, with the new repurchase date set for April 26, 2026 [1][2][3] - Hubei Hongtai Group pledged 350,000,000 shares of Hubei Energy Group to CITIC Securities, with the initial pledge date on April 26, 2023, and the original maturity date on April 26, 2024 [1][2] - As of the announcement date, there is no risk of forced liquidation for the pledged shares held by Hubei Hongtai Group, and it will not have a substantial impact on the company's operations and governance [4] Group 2 - The company has committed to timely information disclosure in accordance with relevant regulations if there are significant changes in the pledged situation [4] - The announcement includes a notice from Hubei Hongtai Group regarding the extension of the stock pledge and a detailed list from China Securities Depository and Clearing Corporation [5] - The board of directors of Hubei Energy Group guarantees the authenticity, accuracy, and completeness of the disclosed information [6]

◎记者 王彦琳 多家券商在2024年年报中披露了各类重大诉讼事项。其中，证券虚假陈述、股票质押式回购、融资融券 等交易纠纷是券商"踩雷"高发领域。 相关诉讼高发地带折射出券商业务发展的"风险点"，同时也拷问着中介机构的执业质量。业内人士认 为，券商等中介机构要持续完善风控措施，把勤勉尽责和合规放在首位，切实履行好"看门人"职责。 还有券商与上市公司展开互相诉讼。招商证券在2024年年报中称，于2024年10月14日收到上海金融法院 寄送的中安科诉公司服务合同纠纷案。中安科主张公司作为案涉项目的财务顾问，未按照约定履行财务 顾问的职责，损害了其利益并造成损失，据此要求公司承担相应损失。公司将积极组织相关应诉工作。 据中安科此前公告，中安科请求判令招商证券向其赔偿各项损失合计15亿元。 招商证券也对中安科发起了诉讼。2024年10月24日，招商证券以中安科、中安消技术有限公司、深圳市 中恒汇志投资有限公司、涂国身、银信资产评估有限公司、瑞华会计师事务所（特殊普通合伙）等中安 科虚假陈述系列案责任主体为被告，向上海金融法院提起追偿权之诉。 多家券商涉证券虚假陈述诉讼 证券虚假陈述是引发券商诉讼的一大"风险点"。在这 ...